Asciminib |
Asciminib : Allosteric inhibitor of ABL1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| ABL1 |
|
|
Allosteric
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
ABL001 lacks activity against more than 60 kinases, including SRC. Inactive against G-protein-cou ...
In Cell Selectivity Assessment
Selectivity Assessment Description:
Cellular activity of ABL001was determined in 450 cancer cell lines from the Cancer Cell Line Ency ...
Potency Cellular
In Vitro
ABL1
Mode of Action: Allosteric
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/nature21702
In Vivo Validations
Mouse, Rat, Dog
Dose: 1 (M), 2(R), 1(D) mg/Kg IV, 30 (M), 30 (R), 15 (D) 30 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
1.1(M), 2.7(R), 3.7(D) h
Systemic clearance:
12 (M), 16 (R), 6 (D) mL/min/kg
DOI Reference: 10.1038/nature21702
Chemical Information
| Molecular Formula | C20H18ClF2N5O3 |
| SMILEs | O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1 |
| InChI | InChI=1S/C20H18ClF2N5O3/c21-20(22,23)31-15-3-1-13(2-4-15)26-19(30)12-9-16(17-5-7-25-27-17)18(24-10-12)28-8-6-14(29)11-28/h1-5,7,9-10,14,29H,6,8,11H2,(H,25,27)(H,26,30)/t14-/m1/s1 |
| Molecular weight | 449.11 Da |
| AlogP | 0.0 |
| HBond acceptors | 8 |
| HBond donors | 3 |
| Atoms | 49 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.